Glioblastoma Foundation Inc

TO TRANSFORM THE STANDARD OF CARE FOR GLIOBASTOMA BY SUPPORTING THE DEVELOPMENT OF TARGETED THERAPIES THAT WORK FOR ALL GLIOBLASTOMA PATIENTS. TO ALSO SUPPORT AWARENESS AND EDUCATION EFFORTS FOR GLIOBLASTOMA AS WELL AS PROVIDING PATIENT RESOURCES FOR INDIVIDUALS DIAGNOSED WITH GLIOBLASTOMA.

OVER THE PAST FIVE YEARS SINCE ITS INCEPTION, THE GLIOBLASTOMA FOUNDATION HAS PROVIDED FUNDING FOR SEVERAL NEW DRUGS AND OTHER INNOVATIVE THERAPIES TO EXTEND SURVIVAL AN IMPROVE PATIENT QUALITY OF LIFE FOR THOSE IMPACTED BY GLIOBLASTOMA. THE GLIOBLASTOMA FOUNDATION IS THE ONE AND ONLY NATIONAL NON PROFIT COMMITTED TO FUNDING NEW, MORE EFFECTIVE THERAPIES FOR GLIOBLASTOMA THAT WILL WORK FOR ALL PATIENTS. OVER ITS HISTORY, THE GLIOBLASTOMA FOUNDATION HAS FUNDED TRIALS FOR THE FOLLOWING DRUGS FOR GLIOBLASTOMA INCLUDING MEBENDAZOLE AT JOHNS HOPKINS UNIVERSITY AND HSP-90 INHIBITOR DRUGS AT OHIO STATE UNIVERSITY.ONE OF THE GLIOBLASTOMA FOUNDATION'S KEYNOTE INITIATIVES IS THE OSIMERTINIB TRIAL. THE DRUG OSIMERTINIB HAS BEEN SHOWN TO BE EFFECTIVE AT EXTENDING LIFE FOR A SUBSTANTIAL SUBSET OF GLIOBLASTOMA PATIENTS. THE GLIOBLASTOMA FOUNDATION HAS WORKED TO MAKE THIS DRUG AVAILABLE FOR ALL GLIOBLASTOMA PATIENTS AND IS CURRENTLY FUNDING A MULTI-CENTER, NATIONAL CLINICAL TRIAL TO GET THIS DRUG APPROVED FOR GLIOBLASTOMA PATIENTS. STUDY SITES FUNDED BY THE GLIOBLASTOMA FOUNDATION INCLUDE UNIVERSITY OF PENNSYLVANIA, WAKE FOREST UNIVERSITY, JOHNS HOPKINS UNIVERSITY, AND OTHERS.THE GLIOBLASTOMA FOUNDATION IS THE NATIONAL LEADER IN FUNDING NEW THERAPIES THAT WILL TRANSFORM GLIOBLASTOMA FROM TERMINAL TO TREATABLE.IN ADDITION TO PROVIDING FUNDING FOR THE OSIMERTINIB TRIAL, THE GLIOBLASTOMA FOUNDATION IS ALSO FUNDING THE ADVANCEMENT OF NEUROSURGICAL TECHNIQUES TO IMPROVE PATIENT SURVIVAL FOR INOPERABLE GLIOBLASTOMAS. OUR STUDY TO IMPROVE SURGICAL TECHNIQUES FOR BRAINSTEM GLIOBLASTOMA WILL RESULT IN PROLONGED SURVIVAL FOR PATIENTS WITH THIS DEADLY TYPE OF GLIOBLASTOMA. SINCE ITS INCEPTION IN 2016, THE GLIOBLASTOMA FOUNDATION HAS PLACED A STRONG FOCUS ON IMPROVING NEUROSURGICAL TECHNIQUES FOR GLIOBLASTOMA. AS PART OF OUR MULTI-PROLONGED, ONE-OF-A KIND NEUROSURGERY RESEARCH AWARD NAMED AFTER THE LATE RUSH DRUMMER NEIL PEART, WE ARE FUNDING NEUROSURGERY RESEARCH AT SEVERAL LEADING RESEARCH CENTERS AROUND THE COUNTRY INCLUDING THE UNIVERSITY OF PITTSBURGH.BY LEVERAGING ITS SCIENTIFIC EXPERTISE AND LEADERSHIP, THE GLIOBLASTOMA FOUNDATION IS UNIQUELY POSITIONED TO IDENTIFY THE BEST NEW THERAPIES WITH THE GREATEST LIKELIHOOD OF SUCCESS FOR IMPROVING PATIENT SURVIVAL AND ULTIMATELY LEADING TO A CURE FOR THIS DEADLY DISEASE.THE GLIOBLASTOMA FOUNDATION IS A TRUSTED SOURCE OF INFORMATION FOR PATIENTS AND FAMILIES IMPACTED BY GLIOBLASTOMA. THROUGH ITS NATIONALLY RECOGNIZED PATIENT SUPPORT PROGRAMS THE GLIOBLASTOMA FOUNDATION PROVIDES IMPORTANT RESOURCES FOR PATIENTS DIAGNOSED WITH GLIOBLASTOMA, INCLUDING CLINICAL TRIALS MATCHING LED BY A CLINICAL STAFF OF PHYSICIANS, RESEARCHERS, AND PHARMACISTS. THE GLIOBLASTOMA FOUNDATION ALSO LEVERAGES ITS SCIENTIFIC AND CLINICAL RESOURCES TO CONNECT PATIENTS WITH SECOND OPINIONS AT LEADING MEDICAL CENTERS ACROSS THE NATION. THE GLIOBLASTOMA FOUNDATION PUBLISHES AND PERIODICALLY UPDATES CLINICAL RESOURCES FOR PATIENTS AND CAREGIVERS THAT HAVE COME TO BE A TRUSTED SOURCE OF INFORMATION FOR THOSE BATTLING GLIOBLASTOMA.GLIOBLASTOMA IS A RARE, DEADLY GRADE 4 BRAIN TUMOR THAT IS TERMINAL 95% OF THE TIME. THE GLIOBLASTOMA FOUNDATION HAS WORKED TO ENSURE THAT EVERYONE KNOWS WHAT A SERIOUS CONDITION GLIOBLASTOMA IS. THROUGH ITS LONG-STANDING NATIONAL PARTNERSHIP WITH THE LOS ANGELES MARATHON, THE GLIOBLASTOMA FOUNDATION HAS HELPED RAISE AWARENESS OF GLIOBLASTOMA. THE GLIOBLASTOMA FOUNDATION ALSO RAISES AWARENESS THROUGH ANNUAL KEYNOTE EVENTS LIKE OUR "GLIOBLASTOMA AWARENESS GALA" HELD EACH YEAR IN WASHINGTON, DC AND OUR "GET UP FOR GLIOBLASTOMA" HALF MARATHON HELD EACH MAY.